These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8321084)

  • 21. Effect of 5-HT2-selective agonists on cat platelet aggregation.
    Seggel MR; Qureshi GD; Glennon RA
    Life Sci; 1987 Aug; 41(9):1077-81. PubMed ID: 3613863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.
    Affolter H; Erne P; Bürgisser E; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):337-42. PubMed ID: 6427633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.
    De Clerck F; Xhonneux B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S23-5. PubMed ID: 2412050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of serotonin in thrombogenesis.
    De Clerck F
    Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
    Polanski M; Karnovsky ML
    J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets].
    Rotllan E; Escolar G; Ordinas A; Bastida E
    Sangre (Barc); 1993 Apr; 38(2):115-9. PubMed ID: 8390724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.
    Gleerup G; Persson B; Hedner T; Winther K
    Eur J Clin Pharmacol; 1993; 44(2):121-5. PubMed ID: 8453957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress.
    Moritz MW; Reimers RC; Baker RK; Sutera SP; Joist JH
    J Lab Clin Med; 1983 Apr; 101(4):537-44. PubMed ID: 6833826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
    Chaudhary PK; Kim S
    J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP.
    Peerschke EI
    Blood; 1982 Jul; 60(1):71-7. PubMed ID: 6282365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men.
    Gow IF; Dockrell M; Edwards CR; Elder A; Grieve J; Kane G; Padfield PL; Waugh CJ; Williams BC
    Eur J Clin Pharmacol; 1992; 43(6):635-8. PubMed ID: 1493845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.